Beijing suspends Ali Health-run online drug monitoring platform
Authorities drafting amendments to rules monitoring pharmaceutical sales
Add BT as a preferred sourceBeijing
CHINA'S food and drugs regulatory body said it had suspended its electronic drug monitoring system, a platform operated by Alibaba Health Information Technology Ltd, while it drafts amendments to regulations monitoring pharmaceutical sales.
The China Food and Drug Administration (CFDA) said that it will seek comments until March 23 on changes to the way pharmaceutical products are monitored, including online sales, according to statements posted on its website on Saturday.
TRENDING NOW
Jumbo Seafood to close flagship East Coast Seafood Centre outlet on Sep 30
Shanda co-founder sells Tanglin Hill bungalow for S$76 million
Singapore developer in limbo after Timor-Leste scraps major township project
Trek 2000 shares jump 41.5% after Osim founder Ron Sim drops claims, sells 7.3% stake to Azure Capital
